Dimensional Fund Advisors’s OnKure Therapeutics OKUR Stock Holding History

Dimensional Fund Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$209K	Buy	76,928 +8,365	+12%	+$31.6K	﹤0.01%	3062
2026 Q2	$312K	Buy	+68,563	New	+$294K	﹤0.01%	3023
2024 Q4	–	Sell	-1,333	Closed	-$22.7K	–	3371
2024 Q3	$22.7K	Hold	1,333	–	–	﹤0.01%	3330
2024 Q2	$20.1K	Hold	1,333	–	–	﹤0.01%	3351
2024 Q1	$22.1K	Hold	1,333	–	–	﹤0.01%	3362
2023 Q4	$21.3K	Sell	1,333 -3,650	-73%	-$227K	﹤0.01%	3385
2023 Q3	$379K	Sell	4,983 -370	-7%	-$25.2K	﹤0.01%	3098
2023 Q2	$351K	Buy	5,353 +1,651	+45%	+$133K	﹤0.01%	3133
2023 Q1	$221K	Buy	+3,702	New	+$134K	﹤0.01%	3185
2022 Q3	$62K	Buy	+1,842	New	+$60.5K	﹤0.01%	3381

Other funds holding OKUR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Dimensional Fund Advisors's OKUR Position: Q3 2026 in Review

Dimensional Fund Advisors increased its OnKure Therapeutics (OKUR) stake by 12% in Q3 2026, buying an estimated $31.6K and bringing the position to 76,928 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #3062.

Dimensional Fund Advisors first reported a position in OKUR in Q3 2022 and has held it in 10 quarters since. The position peaked at $379K in Q3 2023. 12 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

Dimensional Fund Advisors held 76,928 shares of OnKure Therapeutics worth $209K as of Q3 2026.
Dimensional Fund Advisors bought 8,365 OnKure Therapeutics shares in Q3 2026, an estimated $31.6K.
OnKure Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3062 holding.
Dimensional Fund Advisors first reported a position in OnKure Therapeutics in Q3 2022 and has held it in 10 quarters since.
Dimensional Fund Advisors's OnKure Therapeutics position peaked at $379K in Q3 2023.
12 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.